Medico Remedies Limited

BSE: 540937 NSE: MEDICO
Medico Remedies Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN L24230MH1994PLC077187 Incorporated 18 March 1994 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - NSE: MEDICO · BSE: 540937 Public Limited Company pharma MSME
Market Cap
₹155 Cr
MEDICO · NSE
Share Price
₹18.44
-1.23% today
Revenue
₹206 Cr
FY 2025-26 · +36.7% YoY
EBITDA
₹17.03 Cr
Margin 8.2%
Net Profit
₹13.10 Cr
FY 2025-26 · +29.7% YoY
P/E (TTM)
11.5x
P/B 2.0x
ROE
19.0%
ROCE 23.2%
Debt / Equity
0.24
Interest cover 13.0x

About Medico Remedies Limited

Data last updated:

Medico Remedies Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 March 1994 and has been in existence for over 32 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L24230MH1994PLC077187. Its GSTIN is 27AABCM8349L1ZY (Maharashtra). It is a listed company as per MCA records. Its shares are listed on BSE: 540937 and NSE: MEDICO.

The company has an authorised share capital of ₹17 Cr and a paid-up capital of ₹16.6 Cr. It was formerly known as Medico Remedies P Ltd and Medico Remedies Private Limited. It is led by directors including Harshit Haresh Mehta (Managing Director) and Haresh Kapurlal Mehta (Whole-Time Director).

Its last annual general meeting (AGM) was held on 22 September 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Mumbai, Maharashtra.

As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹206.38 Cr, a growth of 36.7% compared to the previous year. For the same year it recorded a net profit of ₹13.1 Cr (net margin 6.3%) and EBITDA of ₹17.03 Cr (EBITDA margin 8.3%). The net worth stands at ₹75.48 Cr (up 20.8% YoY). Total assets are valued at ₹94.38 Cr (up 23.1% YoY).

The company has about 78 employees on its provident fund (EPFO) records.

The company is associated with 2 brands: Medico Remedies and Medicoremedies. As per MCA filings, the company has open charges of ₹76.84 Cr and satisfied charges of ₹39.66 Cr on record. Court records list 17 cases involving the company, including 8 filed by the company and 9 filed against it; 3 cases are pending. The company has 80 deals on record (78 market trades, 1 ipo, 1 secondary share transfer); the latest was in August 2026.

Medico Remedies Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-18-0010876). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medicoremediesindia.com.

Company details

CIN L24230MH1994PLC077187
Registration Number 077187
Incorporation Date 18 March 1994
ROC Mumbai
Listing Status Listed - Listed on NSE (MEDICO); Listed on BSE (540937)
Company Status Active
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-18-0010876

Name history

Medico Remedies has undergone 2 name changes throughout its history. The company was previously known as Medico Remedies P Ltd, and Medico Remedies Private Limited. The current legal name is Medico Remedies Limited.

Company NameStatus
Medico Remedies LimitedCurrent
Medico Remedies P LtdPrevious
Medico Remedies Private LimitedPrevious

CIN history

Medico Remedies has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24230MH1994PLC077187, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L24230MH1994PLC077187Current
U24230MH1994PLC077187Previous
U24230MH1994PTC077187Previous
Key People
Harshit Haresh Mehta Managing Director Haresh Kapurlal Mehta Whole-Time Director Rishit Hareshbhai Mehta Whole-Time Director

Recognitions & Rankings of Medico Remedies

MSME (Udyam registered) Ministry of MSME
Udyam number
UDYAM-MH-18-0010876

Contact details

Medico Remedies Limited's registered office is in Mumbai, Maharashtra. Its website is medicoremediesindia.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    medicoremediesindia.com
  • Registered Address
    1105/1106 11th Floor Hubtown Solaris Opp. Telli Galli N S Phadke Marg Andhe, Ri East, Mumbai, Maharashtra, India – 400069
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Medico Remedies Limited, buy the company report.

Comprehensive company report
Medico Remedies Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Medico Remedies operates two associated brands: Medico Remedies and Medicoremedies. Each brand links to its own profile.

BrandDescriptionWebsite
Medico Remedies
Pharmaceutical formulations are manufactured by Medico Remedies.medicoremediesindia.com
Medicoremedies
Pharmaceutical formulations are manufactured, emphasizing anti-infectives and therapeutic drugs.medicoremedies.com

Business activity

The main business activity of Medico Remedies is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing21Manufacture of basic pharmaceutical products and pharmaceutical preparations

To see the full business activity and turnover split of Medico Remedies Limited, buy the company report.

Financials of Medico Remedies Limited

FY 2025-26 filings available

Medico Remedies Limited reported revenue of ₹206.38 Cr (up 36.7% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Standalone
Revenue
₹206 Cr
+36.7% YoY
EBITDA
₹17.03 Cr
+13.5% YoY
Profit After Tax
₹13.10 Cr
+29.7% YoY
Net Worth
₹75.48 Cr
+20.8% YoY
Total Assets
₹94.38 Cr
+23.1% YoY
Total Debt
₹18.91 Cr
+36.6% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue20615114514012112288.64
Revenue growth+36.7%+4.2%+3.2%+16.1%-1.1%+38.1%-
EBITDA17.0315.0112.919.627.345.242.84
EBITDA margin+8.3%+9.9%+8.9%+6.9%+6.1%+4.3%+3.2%
Profit before tax18.0613.5111.3410.106.493.702.22
Net profit13.1010.108.297.244.852.591.64
Net profit margin+6.4%+6.7%+5.7%+5.2%+4.0%+2.1%+1.9%
EPS (₹)1.581.221.000.872.906.243.93
Balance sheet
Total assets94.3876.6760.4253.9649.2947.6143.74
Net worth75.4862.4752.3743.8536.5832.4629.87
Total debt18.9113.848.059.7712.6015.0513.87
Cash & bank1.911.090.180.912.342.831.42
Net working capital68.0652.1036.7229.9629.4629.5725.33
Cash flow
Cash from operations5.874.892.448.175.86(11.31)0.97
Cash from investing(4.51)(3.46)(2.68)(6.60)(1.76)(16.96)(3.08)
Cash from financing(0.55)(0.52)(0.49)(1.82)(5.77)18.282.60
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue73.9769.4056.8158.6852.6438.2541.3039.49
Revenue growth (YoY)+40.5%+81.4%+37.6%+48.6%+33.8%+24.2%--
Other income1.311.172.870.681.720.660.291.43
Total expenses70.8166.1049.6654.3549.9235.4334.6436.38
EBITDA3.163.307.154.332.722.826.663.11
EBITDA margin+4.3%+4.8%+12.6%+7.4%+5.2%+7.4%+16.1%+7.9%
Depreciation0.750.720.800.790.730.770.770.76
Interest0.450.410.900.390.240.280.490.28
Profit before tax3.273.348.323.833.472.435.693.50
Tax0.890.822.470.960.900.621.360.88

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 15 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue73.9769.4056.8158.6852.6438.2541.3039.49
Revenue growth (YoY)+40.5%+81.4%+37.6%+48.6%+33.8%+24.2%--
Other income1.311.172.870.681.720.660.291.43
Total expenses70.8166.1049.6654.3549.9235.4334.6436.38
EBITDA3.163.307.154.332.722.826.663.11
EBITDA margin+4.3%+4.8%+12.6%+7.4%+5.2%+7.4%+16.1%+7.9%
Depreciation0.750.720.800.790.730.770.770.76
Interest0.450.410.900.390.240.280.490.28
Profit before tax3.273.348.323.833.472.435.693.50
Tax0.890.822.470.960.900.621.360.88
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue20615114514012112288.64
Revenue growth+36.7%+4.2%+3.2%+16.1%-1.1%+38.1%-
Other income5.932.692.133.952.031.032.10
Total expenses18913613213111411785.80
Employee cost5.714.705.925.685.414.503.83
EBITDA17.0315.0112.919.627.345.242.84
EBITDA margin+8.3%+9.9%+8.9%+6.9%+6.1%+4.3%+3.2%
Depreciation3.093.032.882.722.221.651.66
Interest1.811.160.820.750.660.921.06
Profit before tax18.0613.5111.3410.106.493.702.22
Tax4.953.413.052.861.671.110.58
Net profit13.1010.108.297.244.852.591.64
Net profit margin+6.4%+6.7%+5.7%+5.2%+4.0%+2.1%+1.9%
EPS (₹)1.581.221.000.872.906.243.93
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital16.6016.6016.6016.6016.604.154.15
Reserves & surplus58.8845.8735.7727.2519.9828.3125.72
Shareholders' funds (net worth)75.4862.4752.3743.8536.5832.4629.87
Secured loans17.1512.755.907.8510.3712.7913.04
Unsecured loans1.761.092.151.922.232.260.83
Total debt18.9113.848.059.7712.6015.0513.87
Total liabilities94.3876.6760.4253.9649.2947.6143.74
Assets
Gross block44.4142.7141.3538.8032.3928.8724.36
Net block20.4121.2921.5021.8318.0315.3112.54
Capital work in progress2.570.360.000.070.000.002.28
Investments1.891.651.571.270.001.170.15
Inventories30.0226.7316.3419.7018.1114.5518.26
Sundry debtors81.9957.1849.6336.0930.3927.4223.89
Cash & bank balances1.911.090.180.912.342.831.42
Loans & advances13.1610.226.206.576.7312.6213.07
Total current assets12795.2272.3563.2757.5757.4256.64
Total current liabilities59.0243.1235.6333.3128.1127.8531.31
Net working capital68.0652.1036.7229.9629.4629.5725.33
Total assets94.3876.6760.4253.9649.2947.6143.74
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash1.090.180.911.172.830.000.16
Net cash from operating activities5.874.892.448.175.86(11.31)0.97
Net cash from investing activities(4.51)(3.46)(2.68)(6.60)(1.76)(16.96)(3.08)
Net cash from financing activities(0.55)(0.52)(0.49)(1.82)(5.77)18.282.60
Net change in cash0.810.91(0.73)(0.25)(1.67)(9.99)0.48
Closing cash1.911.090.180.912.342.831.42
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+36.7%+4.2%+3.2%+16.1%-1.1%+38.1%-
EBITDA growth+13.5%+16.3%+34.2%+31.1%+40.1%+84.5%-
PBT growth+33.7%+19.1%+12.3%+55.6%+75.4%+66.7%+2.3%
Net income growth+29.7%+21.8%+14.5%+49.3%+87.3%+57.9%-
Revenue CAGR (3Y)+13.7%+7.6%+5.8%+16.6%+7.4%+26.1%+17.7%
EBITDA CAGR (3Y)+21.0%+26.9%+35.1%+50.2%+38.6%+14.5%-8.4%
Profitability & leverage
Net income margin+6.4%+6.7%+5.7%+5.2%+4.0%+2.1%+1.9%
Return on capital employed+23.2%+21.4%+21.2%+21.0%+14.7%+10.1%+7.6%
Return on net worth+19.0%+17.6%+17.2%+18.0%+13.9%+8.3%+5.6%
Debt / equity0.240.190.190.280.400.460.47
Long-term debt / equity0.000.010.020.050.110.150.12
Interest cover12.989.688.1810.8712.8925.6389.83
Efficiency & per share
Fixed asset turnover4.743.593.623.953.954.603.79
Inventory turnover7.277.018.047.437.417.465.16
Debtors turnover2.972.833.384.234.194.773.35
EPS (₹)1.581.221.000.872.906.243.93
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)9.107.536.315.2822.0478.2271.98

To see the full year-wise statements and ratios of Medico Remedies Limited, buy the company report.

Board of directors of Medico Remedies Limited

Medico Remedies has 10 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rita Haresh MehtaDirector08 Dec 199926 Years 11 MonthsCurrent
Haresh Kapurlal MehtaWhole-Time Director18 Mar 199432 Years 7 MonthsCurrent
Harshit Haresh MehtaManaging Director14 Dec 201114 Years 11 MonthsCurrent
Rishit Hareshbhai MehtaWhole-Time Director12 Mar 201511 Years 8 MonthsCurrent
Deepak Maganlal VekariaDirector25 Sep 20179 Years 1 MonthsCurrent
Bharat Nathalal Rathod
Also directs: Atulya Innovatives LLP, M. R. Sanghavi Bio Private Limited
Director25 Sep 20179 Years 1 MonthsCurrent
Showing 6 of 10 current directors. View all directors

Auditor

Medico Remedies Limited is audited by V J Shah & Co for the financial year 2025.

Auditor firmFinancial yearFirm registration number
V J Shah & CoFY 2025109823W

Shareholding

Shareholding for the quarter ended Sep 2026: promoters hold 61.40%, foreign institutional investors hold 0.10%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 38.60%.

Promoters: 61.40%FII (Foreign Institutional): 0.10%Retail & Others: 38.60%
Sep 2026
QUARTER
61.40% Promoters
0.10% FII (Foreign Institutional)
38.60% Retail & Others
Promoter holding - history
Now 61.40% · Sep 2026High 61.40% · Dec 2025Low 61.40% · Dec 2025
60%60.8%61.5%62.3%63%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 61.40%Mar 2026: 61.40%Jun 2026: 61.40%Sep 2026: 61.40%61.40%61.40%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters61.40%61.40%61.40%61.40%
Public38.60%38.60%38.60%38.60%

Charges & borrowings

Open charges
₹76.84 Cr
Satisfied charges
₹39.66 Cr
Breakdown by lending institutions
Others₹76.84 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
07 Aug 2026101360545Others₹3.46 CrOpen
20 Dec 2018100226011Others₹24.08 CrOpen
31 Jul 2018100207287Others₹49.3 CrOpen
31 Aug 2019100290953Others₹2.75 CrSatisfied
31 Aug 2019100302589Others₹2.75 CrSatisfied

To see the full charge records of Medico Remedies Limited, buy the company report.

Total charge records: 10 View all charges

Deals & funding

Medico Remedies Limited has 80 deals on record (78 market trades, 1 ipo, 1 secondary share transfer); the latest was in August 2026.

Total deals
80
Market trades
78
IPO
1
Secondary share transfer
1

Deals on record (5 of 80)

WhenDealAmountParties
Aug 2026Market trade₹2.08 CrBuyer: L7 Hitech Private Limited
Jan 2026Market trade₹7.4 CrBuyer: Altizen Ventures LLP , an individual
Seller: Altizen Ventures LLP
Sep 2025Market trade₹3.12 CrSeller: Aryaman Capital Markets Limited
Jun 2025Market trade₹5.01 CrBuyer: Pashupati Capital Services Private Limited
Seller: Pashupati Capital Services Private Limited
Jun 2025Market trade₹2.81 CrBuyer: Pashupati Capital Services Private Limited
Seller: Pashupati Capital Services Private Limited

To see the full deal history of Medico Remedies Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Medico Remedies Limited was last rated by Brickwork on 16 Sep 2020.

Rating agencyRated onRating
Brickwork16 Sep 2020

To see the full credit ratings and regulatory alerts of Medico Remedies Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Medico Remedies Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Medico Remedies Limited has a workforce of 78 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
78
Active EPFO establishments
1
Employee growth
21.9%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2778
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Medico Remedies Limited, buy the company report.

GST

Medico Remedies has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AABCM8349L1ZYMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Medico Remedies Limited, buy the company report.

Recent activity

Medico Remedies Limited has 20 board changes on record since 1994: 15 appointments and 5 cessations. The latest: Hasan Bohra ceased to be Company Secretary on 08 Aug 2025.

Charges
A charge with Others of Rs. 49.30 Cr registered on 31 Jul 2018 with Charge ID 100207287 was modified on 24 Sep 2026.
AGM
Medico Remedies Limited last Annual general meeting of members was held on 22 Sep 2026 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 3.46 Cr with Charge ID 101360545 was registered on 07 Aug 2026.
Charges
A charge with Others of Rs. 3.46 Cr registered on 07 Aug 2026 with Charge ID 101360545 was modified on 07 Aug 2026.
Filing
Medico Remedies Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai I.
Ceased
Hasan Bohra ceased to be Company Secretary.
Appointed
Maheshkumar Rameshchandra Darji was appointed as Director.
Ceased
Dayanad Shivshankar Mathapati ceased to be Whole-Time Director.
Appointed
Anuj Kishore Mody was appointed as Director.
Appointed
Hasan Bohra was appointed as Company Secretary.
Ceased
Dinesh Navnitlal Modi ceased to be Company Secretary.
Ceased
Ramesh Narandas Rughani ceased to be Director.

34 earlier events are in the company report.

News

Frequently asked questions

Medico Remedies is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 March 1994 (32+ years old) and is registered under CIN L24230MH1994PLC077187. Listed on BSE: 540937 and NSE: MEDICO.

Medico Remedies reported revenue of ₹206.38 Cr for FY 2025-26 (up 36.7% YoY) based on standalone financials.

Medico Remedies has 10 current directors:

The latest financial statements of Medico Remedies on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 22 September 2026. Year-wise statements from 2015 are in the company report.

The GSTIN of Medico Remedies is 27AABCM8349L1ZY, registered in Maharashtra.

The CIN (Corporate Identification Number) of Medico Remedies is L24230MH1994PLC077187. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Medico Remedies is a listed company as per MCA records. Its shares are listed on both BSE (code: 540937) and NSE (symbol: MEDICO).

Medico Remedies has 17 court cases on record: 8 filed by the company and 9 filed against it. 3 are pending. Most are in the district courts.

Medico Remedies was incorporated on 18 March 1994, making it 32+ years old. It is registered with the Registrar of Companies, Mumbai.

Medico Remedies has 80 deals on record (78 market trades, 1 ipo, 1 secondary share transfer); the latest was in August 2026.